ACTRN12622000701729
Completed
未知
Better management of breathlessness in the ICU (BreatheICU): A cross-sectional national clinician survey and consumer interview study.
Mr Leigh Rushworth0 sites160 target enrollmentMay 16, 2022
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Mr Leigh Rushworth
- Enrollment
- 160
- Status
- Completed
- Last Updated
- last year
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Medical, nursing and allied health staff of Australian adult ICU’s will be invited to participate in a single survey. With endorsement of the study by the ANZICS CTG we anticipate the survey will be able to be distributed to over 70 ANZICS CTG member ICU’s in Australia, reaching a minimum of 500 eligible clinicians on the CTG mailing list. Mailing list recipients will be encouraged to forward the survey invitation to eligible clinicians within their networks (snowballing).
- •A purposive sample of patients admitted to the ICU with and without respiratory disease (n\=20 patients) over a four\-month period will be recruited. Clinical staff at The Queen Elizabeth Hospital, South Australia (TQEH) will screen ICU patients Monday to Friday for the following inclusion criteria:
- •Aged over 18 years
- •English speaking
- •ICU stay of \>48 hours
- •Planned for discharge from the ICU to the ward
- •Capacity to provide consent to participate
- •Patients meeting the above inclusion criteria will be asked a single screening question \- Did you ever feel breathless during your time in ICU?”. Those indicating ‘yes’ will be invited to participate in a semi\-structured interview.
Exclusion Criteria
- •No specific groups are to be excluded.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Breathlessness training: comparison of two programmes for Shortness Of Breath in Lung CancerBreathlessness in patients with intrathoracic malignancyCancerMalignant neoplasm of other and ill-defined sites in the respiratory system and intrathoracic organsISRCTN62865905Hull and East Yorkshire Hospitals NHS Trust (UK)40
Completed
Not Applicable
Improving Management of Breathlessness in Patients With Lung CancerBreathlessnessDyspneaLung CancerNCT01937637Massachusetts General Hospital32
Active, not recruiting
Phase 1
BETTER-B: Better Treatments for Refractory Breathlessness.Refractory breathlessness in patients diagnosed with chronic obstructive pulmonary disease (COPD) or interstitial lung disease (ILD).MedDRA version: 21.1Level: LLTClassification code 10009032Term: Chronic obstructive lung diseaseSystem Organ Class: 100000004855Therapeutic area: Diseases [C] - Respiratory Tract Diseases [C08]EUCTR2019-002001-21-ITniversity College Dublin324
Active, not recruiting
Phase 1
BETTER-B: Better Treatments for Refractory Breathlessness.Refractory breathlessness in patients diagnosed with chronic obstructive pulmonary disease (COPD) or interstitial lung disease (ILD).Therapeutic area: Diseases [C] - Respiratory Tract Diseases [C08]EUCTR2019-002001-21-GBKing's College London324
Active, not recruiting
Phase 1
BETTER-B: Better Treatments for Refractory Breathlessness.EUCTR2019-002001-21-IEniversity College Dublin324